会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明公开
    • KIDNEY-TARGETED DRUG DELIVERY SYSTEMS
    • KIDNEY-TARGETED药物输送系统
    • EP3217947A1
    • 2017-09-20
    • EP15859214.7
    • 2015-11-12
    • University of Mississippi Medical Center
    • CHADE, Alejandro R.BIDWELL III, Gene L.
    • A61K8/04
    • A61K47/64A61K38/1866A61K38/39A61K47/6435A61P13/12A61K2300/00
    • A composition including an elastin-like polypeptide (ELP) coupled to a kidney targeting peptide and. a therapeutic agent is provided. A method of delivering a therapeutic agent to a subject in need thereof comprising: administering to the subject an effective amount of a composition comprising: an elastin-like polypeptide (ELP), a kidney targeting agent coupled to the ELP and a targeting agent and/or a drug binding domain coupled to the ELP, wherein the ELP includes an amino acid sequence having at least about repeats of the amino acid sequence GVPGX (SEQ ID NO: 1), and wherein the composition enhances the deposition and retention of the therapeutic agent in the kidney relative to the non-conjugated therapeutic.
    • 包含与肾靶向肽偶联的弹性蛋白样多肽(ELP)的组合物。 提供治疗剂。 向有需要的受试者递送治疗剂的方法,其包括:给受试者施用有效量的组合物,所述组合物包含:弹性蛋白样多肽(ELP),与ELP偶联的肾靶向剂和靶向剂,以及 /或与所述ELP偶联的药物结合结构域,其中所述ELP包含具有至少约氨基酸序列GVPGX(SEQ ID NO:1)的重复序列的氨基酸序列,并且其中所述组合物增强所述治疗剂的沉积和保留 相对于非共轭治疗剂而言,在肾中的药物。